Skip to content

Clinical research

Clinical trial sites in China

Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.

  • Trial site
  • Group of pins (click to zoom)

Showing the 40,000 busiest of 46,305 located sites. The map holds only the first 40,000, so narrow the filters to see the rest.

Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.

Looking for contract research suppliers and CROs? Visit Contract Research Map

Looking to track new and ongoing clinical trials? Visit Trial Insights

Filters: Country: China Clear all

Trial sites by region

Select a bar to filter by region.

Scale
Trial sites by region
CategoryTrial sites
Asia-Pacific46,305

Top countries

Country of the site's address. Select a bar to filter.

Scale

Bar colour shows the country's region, as in the chart by region.

Trial sites by country
CategoryTrial sites
United States307,932
France73,380
Germany73,266
Italy48,719
China46,305
Japan38,861
Spain36,598
United Kingdom32,508

Trial sites

46,305 sites. Sites with a public page link to it on Pharma Observatory.

  • Department of Hepatobiliary Surgery, Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China 1 trial
  • Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University Yinchuan, Ningxia, China 1 trial
  • Department of Hepatobiliary Surgery, General Hospital of Ningxia Medical University Yinchuan, China 1 trial
  • Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center,Sun Yat-Sen University Guangzhou, Guangdong, China 1 trial
  • Department of Hepatobiliary Surgery, Sun-Yat Sen Memorial Hospital Guangzhou, Guangdong, China 1 trial
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China Ongoing trial 1 trial
  • Department of Hepatobiliary Surgery, the First Affiliated Hospital of Air Force Military Medical University XiAn, Shanxi, China Ongoing trial 1 trial
  • Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital of Naval Medical UniversityUniversity Shanghai, Shanghai Municipality, China 1 trial
  • Department of Hepatobiliary and Pancreatic Surgery, Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, China Shanghai, China 1 trial
  • Department of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China 1 trial
  • Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University Guangzhou, Guangdong, China 1 trial
  • Department of Hepatology and Infection, Tongren Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China 1 trial
  • Department of Hepatology of Beijing Ditan Hospital Capital Medical University Beijing, China 1 trial
  • Department of Hepatopancreatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China 1 trial
  • Department of ICU, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital Chengdu, Sichuan, China 1 trial
  • Department of Immunology and Rheumatology, Qingdao Municipal Hospital Qingdao, Shandong, China 1 trial
  • Department of Implantology, School of Stomatology, Peking University Beijing, China 1 trial
  • Department of Infection of Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai, China 1 trial
  • Department of Infections Disease of Peking University First Hospital Beijing, Beijing Municipality, China 1 trial
  • Department of Infectious Disease of Wu Han Union Hospital Wuhan, Hubei, China 1 trial

Explore the data behind the map on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.